Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency

Completed

• Conditions: Internal Medicine; Transferrin; Iron-deficiency; Ferritinemia

• Registration Number: NCT04139265
• Lead Sponsor: Lille Catholic University

Brief Summary

Transferrin saturation coefficient and ferritinemia in diagnosis of iron deficiency

Detailed Description

Not available

Study Timeline

• Study Start: 2019-06-06
• Primary Completion: 2019-09-30
• Study Completion: 2019-09-30
• Status Verified: 2019-10
• Study First Submitted: 2019-10-23
• Study First Submitted QC: 2019-10-23
• Last Update Submitted: 2019-10-23
• Study First Posted: 2019-10-25
• Last Update Posted: 2019-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 136

Inclusion Criteria

• ≥ 65 years old
• Patient hospitalized in the internal medicine and geriatry service
• Patient affiliated with a social security scheme
• Patient signed an Informed consent

Exclusion Criteria

• Risk benefit balance not in favor of iron deficiency check-up
• Patient in palliative care

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Agreement between Transferrin Saturation Coefficient (TSC) and ferritinemia dosage	Day one	The overall agreement, assessed by kappa Cohen

Secondary Outcome Measures

Name	Time	Method
Prevalence of iron deficiency in patients with anticoagulant and platelet aggregation inhibitor	Day one
Prevalence of iron deficiency with and without anaemia	Day one	Number of patients with iron deficiency with or without anaemia
Prevalence of etiologies of iron deficiency	Day one	Number of patients for each etiology

Trial Locations

Locations (1)

Saint-Philibert hospital; 🇫🇷 Lomme, Nord, France